This study sought to determine whether the cannabis constituent, cannabidiol (CBD), is able to attenuate morphine reward in the conditioned place preference (CPP) paradigm. Mice received IP injections of either saline or morphine and increasing doses of CBD that were paired with a distinct environment in the CPP apparatus. Morphine-produced place preference was dose-dependently blocked by CBD. Furthermore, none of the tested doses of CBD exhibited reward or aversion. The finding that CBD blocks opioid reward suggests CBD may be useful as an abuse deterrent, particularly in the setting of opioid use for pain management
There has been a recent surge in popularity for cannabidiol (CBD), a major non-psychotropic constitu...
The present study was designed to explore the relationship between the cannabinoid and opioid recept...
Background: GABAergic drugs can modulate the rewarding properties of morphine. The objective of this...
This study sought to determine whether the cannabis constituent, cannabidiol (CBD), is able to atten...
Researchers have demonstrated interactions between exogenously administered cannabinoid and opioid l...
Delta9-tetrahydrocannbinol (THC), the primary active constituent of Cannabis sativa, has long been k...
The discovery that delta-9-tetrahydrocannabinol (Δ9-THC) is the primary psychoactive ingredient in m...
Opioid abuse is a growing global problem. Current therapies for opioid abuse target withdrawal sympt...
[Background]: Cocaine dependence is an important problem without any effective pharmacological treat...
Nicotine is the central active ingredient in tobacco. The reinforcing effects of nicotine can be stu...
Rationale: Cocaine addiction is a global health problem with no approved pharmacotherapies. Preclini...
Abstracts of the Natural History and Biodiversity Section for the 89th Annual Meeting of the Virgini...
Opioids are powerful analgesics but the clinical utility of these compounds is reduced by aversive o...
Chronic pain affects approximately 100 million American adults and costs the United States upwards o...
Pain associated with cancer is unpredictable and may reflect an inability to quantify it in animals....
There has been a recent surge in popularity for cannabidiol (CBD), a major non-psychotropic constitu...
The present study was designed to explore the relationship between the cannabinoid and opioid recept...
Background: GABAergic drugs can modulate the rewarding properties of morphine. The objective of this...
This study sought to determine whether the cannabis constituent, cannabidiol (CBD), is able to atten...
Researchers have demonstrated interactions between exogenously administered cannabinoid and opioid l...
Delta9-tetrahydrocannbinol (THC), the primary active constituent of Cannabis sativa, has long been k...
The discovery that delta-9-tetrahydrocannabinol (Δ9-THC) is the primary psychoactive ingredient in m...
Opioid abuse is a growing global problem. Current therapies for opioid abuse target withdrawal sympt...
[Background]: Cocaine dependence is an important problem without any effective pharmacological treat...
Nicotine is the central active ingredient in tobacco. The reinforcing effects of nicotine can be stu...
Rationale: Cocaine addiction is a global health problem with no approved pharmacotherapies. Preclini...
Abstracts of the Natural History and Biodiversity Section for the 89th Annual Meeting of the Virgini...
Opioids are powerful analgesics but the clinical utility of these compounds is reduced by aversive o...
Chronic pain affects approximately 100 million American adults and costs the United States upwards o...
Pain associated with cancer is unpredictable and may reflect an inability to quantify it in animals....
There has been a recent surge in popularity for cannabidiol (CBD), a major non-psychotropic constitu...
The present study was designed to explore the relationship between the cannabinoid and opioid recept...
Background: GABAergic drugs can modulate the rewarding properties of morphine. The objective of this...